Around 5,530 employees will be cut from the Research and Development area and in the US, big losses in Connecticut. Lipitor is due to come off patent near the end of this year so sales will be impacted there. Lipitor has not been without issues either this last year as many bottles stunk...
The Medical Quack .... by Barbara Duck
The Medical Quack
Wed, Feb 2 2011
Filed under: Filed under: Medically Related, Pharma/FDA News, drugs, Heart Disease, Pediatrics, Diabetes, Budgets, Pfizer, Research and Development, Lipitor, Job cuts, children, cholesterol, chewable